ID   SH2B2_RAT               Reviewed;         621 AA.
AC   Q9Z200;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   29-MAY-2024, entry version 163.
DE   RecName: Full=SH2B adapter protein 2;
DE   AltName: Full=Adapter protein with pleckstrin homology and Src homology 2 domains;
DE   AltName: Full=SH2 and PH domain-containing adapter protein APS;
GN   Name=Sh2b2; Synonyms=Aps;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION IN NGF SIGNALING, INTERACTION WITH
RP   GRB2; NTRK1; NTRK2 AND NTRK3, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal spinal cord, and Hippocampus;
RX   PubMed=9856458; DOI=10.1016/s0896-6273(00)80620-0;
RA   Qian X., Riccio A., Zhang Y., Ginty D.D.;
RT   "Identification and characterization of novel substrates of Trk receptors
RT   in developing neurons.";
RL   Neuron 21:1017-1029(1998).
RN   [2]
RP   FUNCTION, INTERACTION WITH INSR AND CBL, AND PHOSPHORYLATION.
RX   PubMed=10854852; DOI=10.1016/s0014-5793(00)01621-5;
RA   Ahmed Z., Smith B.J., Pillay T.S.;
RT   "The APS adapter protein couples the insulin receptor to the
RT   phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination
RT   of the insulin receptor.";
RL   FEBS Lett. 475:31-34(2000).
RN   [3]
RP   FUNCTION, INTERACTION WITH CBL AND CAP, AND PHOSPHORYLATION AT TYR-618.
RX   PubMed=11997497; DOI=10.1128/mcb.22.11.3599-3609.2002;
RA   Liu J., Kimura A., Baumann C.A., Saltiel A.R.;
RT   "APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in
RT   response to insulin in 3T3-L1 adipocytes.";
RL   Mol. Cell. Biol. 22:3599-3609(2002).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH INSR; CAP AND CBL.
RX   PubMed=15031295; DOI=10.1074/jbc.m307740200;
RA   Ahn M.-Y., Katsanakis K.D., Bheda F., Pillay T.S.;
RT   "Primary and essential role of the adaptor protein APS for recruitment of
RT   both c-Cbl and its associated protein CAP in insulin signaling.";
RL   J. Biol. Chem. 279:21526-21532(2004).
RN   [5]
RP   INTERACTION WITH ASB6.
RX   PubMed=15231829; DOI=10.1074/jbc.m406101200;
RA   Wilcox A., Katsanakis K.D., Bheda F., Pillay T.S.;
RT   "Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with
RT   APS to enable recruitment of elongins B and C to the insulin receptor
RT   signaling complex.";
RL   J. Biol. Chem. 279:38881-38888(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 401-510 IN COMPLEX WITH
RP   PHOSPHORYLATED INSR, MUTAGENESIS OF ARG-437; LYS-455 AND LYS-457, AND
RP   HOMODIMERIZATION.
RX   PubMed=14690593; DOI=10.1016/s1097-2765(03)00487-8;
RA   Hu J., Liu J., Ghirlando R., Saltiel A.R., Hubbard S.R.;
RT   "Structural basis for recruitment of the adaptor protein APS to the
RT   activated insulin receptor.";
RL   Mol. Cell 12:1379-1389(2003).
CC   -!- FUNCTION: Adapter protein for several members of the tyrosine kinase
CC       receptor family. Involved in multiple signaling pathways. Binds to EPOR
CC       and suppresses EPO-induced STAT5 activation, possibly through a masking
CC       effect on STAT5 docking sites in EPOR. Suppresses PDGF-induced
CC       mitogenesis (By similarity). Involved in stimulation of glucose uptake
CC       by insulin. Involved in coupling from immunoreceptor to Ras signaling.
CC       Acts as a negative regulator of cytokine signaling in collaboration
CC       with CBL. Induces cytoskeletal reorganization and neurite outgrowth in
CC       cultured neurons. {ECO:0000250, ECO:0000269|PubMed:10854852,
CC       ECO:0000269|PubMed:11997497, ECO:0000269|PubMed:15031295,
CC       ECO:0000269|PubMed:9856458}.
CC   -!- SUBUNIT: Homodimer. Interacts with KIT/c-KIT, SHC1, EPOR, PDGFR, VAV1
CC       and VAV3. Interacts (via N-terminal region) with SHC1. Interacts (via
CC       the phosphorylated C-terminus) with GRB2. Interacts (via its SH2
CC       domain) with EPOR, INSR and KIT. Interacts with GRB2 after B-cell
CC       antigen receptor stimulation. Interacts (via PH domain) with VAV3 (By
CC       similarity). Interacts with NTRK1, NTRK2 and NTRK3 (phosphorylated);
CC       after stimulation of the receptor by its extracellular ligand and
CC       subsequent autophosphorylation of the receptor. Binds INSR, GRB2, ASB6
CC       and CAP. Insulin stimulation leads to dissociation of CAP. Binds CBS
CC       only when SH2B2/APS has become phosphorylated. INSR binding does not
CC       depend on the phosphorylation of SH2B2/APS. {ECO:0000250,
CC       ECO:0000269|PubMed:10854852, ECO:0000269|PubMed:11997497,
CC       ECO:0000269|PubMed:14690593, ECO:0000269|PubMed:15031295,
CC       ECO:0000269|PubMed:15231829, ECO:0000269|PubMed:9856458}.
CC   -!- INTERACTION:
CC       Q9Z200; Q9Z200: Sh2b2; NbExp=2; IntAct=EBI-8562298, EBI-8562298;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane. Note=Recruited to the
CC       membrane by binding to an autophosphorylated receptor after receptor
CC       stimulation by its extracellular ligand.
CC   -!- TISSUE SPECIFICITY: Detected in embryonic brain, spinal cord and
CC       cortical neurons. {ECO:0000269|PubMed:9856458}.
CC   -!- PTM: Phosphorylated on a tyrosine residue by NTRK1, NTRK2, NTRK3 and
CC       INSR after stimulation of the receptor by its extracellular ligand.
CC       Tyrosine phosphorylated by JAK2, KIT and other kinases activated by B-
CC       cell receptor in response to stimulation with cytokines, IL3, IL5,
CC       PDGF, IGF1, IGF2, CSF2/GM-CSF and cross-linking of the B-cell receptor
CC       complex (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SH2B adapter family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF095576; AAC64408.1; -; mRNA.
DR   RefSeq; NP_446121.1; NM_053669.1.
DR   RefSeq; XP_008767335.1; XM_008769113.2.
DR   RefSeq; XP_017453727.1; XM_017598238.1.
DR   RefSeq; XP_017453728.1; XM_017598239.1.
DR   PDB; 1RPY; X-ray; 2.30 A; A/B=401-510.
DR   PDB; 1RQQ; X-ray; 2.60 A; C/D=401-510.
DR   PDB; 1YVH; X-ray; 2.05 A; B=609-621.
DR   PDBsum; 1RPY; -.
DR   PDBsum; 1RQQ; -.
DR   PDBsum; 1YVH; -.
DR   AlphaFoldDB; Q9Z200; -.
DR   BMRB; Q9Z200; -.
DR   SMR; Q9Z200; -.
DR   BioGRID; 250306; 1.
DR   IntAct; Q9Z200; 2.
DR   MINT; Q9Z200; -.
DR   STRING; 10116.ENSRNOP00000001935; -.
DR   iPTMnet; Q9Z200; -.
DR   PhosphoSitePlus; Q9Z200; -.
DR   PaxDb; 10116-ENSRNOP00000001935; -.
DR   Ensembl; ENSRNOT00000001935.6; ENSRNOP00000001935.5; ENSRNOG00000001425.6.
DR   Ensembl; ENSRNOT00055000471; ENSRNOP00055000334; ENSRNOG00055000280.
DR   Ensembl; ENSRNOT00060020136; ENSRNOP00060015809; ENSRNOG00060011903.
DR   GeneID; 114203; -.
DR   KEGG; rno:114203; -.
DR   UCSC; RGD:69284; rat.
DR   AGR; RGD:69284; -.
DR   CTD; 10603; -.
DR   RGD; 69284; Sh2b2.
DR   eggNOG; ENOG502QT43; Eukaryota.
DR   GeneTree; ENSGT00950000183191; -.
DR   HOGENOM; CLU_014885_5_0_1; -.
DR   InParanoid; Q9Z200; -.
DR   OMA; YHRMEGT; -.
DR   OrthoDB; 2995825at2759; -.
DR   PhylomeDB; Q9Z200; -.
DR   Reactome; R-RNO-1433559; Regulation of KIT signaling.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   EvolutionaryTrace; Q9Z200; -.
DR   PRO; PR:Q9Z200; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001425; Expressed in spleen and 18 other cell types or tissues.
DR   GO; GO:0005884; C:actin filament; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0001726; C:ruffle; ISO:RGD.
DR   GO; GO:0001725; C:stress fiber; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0035591; F:signaling adaptor activity; ISO:RGD.
DR   GO; GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; ISO:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0050851; P:antigen receptor-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001922; P:B-1 B cell homeostasis; ISO:RGD.
DR   GO; GO:0050873; P:brown fat cell differentiation; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IMP:RGD.
DR   GO; GO:0050776; P:regulation of immune response; ISO:RGD.
DR   GO; GO:0019222; P:regulation of metabolic process; ISO:RGD.
DR   GO; GO:0046578; P:regulation of Ras protein signal transduction; IDA:RGD.
DR   CDD; cd01231; PH_SH2B_family; 1.
DR   CDD; cd10411; SH2_SH2B2; 1.
DR   Gene3D; 6.10.140.110; -; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   IDEAL; IID50237; -.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015012; Phe_ZIP.
DR   InterPro; IPR036290; Phe_ZIP_sf.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR030523; SH2B.
DR   InterPro; IPR035058; SH2B2_SH2.
DR   PANTHER; PTHR10872; SH2B ADAPTER PROTEIN; 1.
DR   PANTHER; PTHR10872:SF4; SH2B ADAPTER PROTEIN 2; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF08916; Phe_ZIP; 1.
DR   Pfam; PF00017; SH2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF109805; Phenylalanine zipper; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Membrane; Phosphoprotein; Reference proteome;
KW   SH2 domain.
FT   CHAIN           1..621
FT                   /note="SH2B adapter protein 2"
FT                   /id="PRO_0000064649"
FT   DOMAIN          186..299
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          409..507
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   REGION          144..165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          507..528
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          548..609
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        548..572
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         47
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JID9"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JID9"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JID9"
FT   MOD_RES         597
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JID9"
FT   MOD_RES         618
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11997497"
FT   MUTAGEN         437
FT                   /note="R->A: Abolishes interaction with phosphorylated
FT                   INSR."
FT                   /evidence="ECO:0000269|PubMed:14690593"
FT   MUTAGEN         455
FT                   /note="K->A: Reduces interaction with phosphorylated INSR."
FT                   /evidence="ECO:0000269|PubMed:14690593"
FT   MUTAGEN         457
FT                   /note="K->N: Abolishes interaction with phosphorylated
FT                   INSR."
FT                   /evidence="ECO:0000269|PubMed:14690593"
FT   MUTAGEN         618
FT                   /note="Y->F: Abolishes phosphorylation in response to
FT                   insulin."
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   HELIX           416..424
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   HELIX           427..430
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   STRAND          434..438
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   STRAND          440..442
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   STRAND          446..452
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   STRAND          455..460
FT                   /evidence="ECO:0007829|PDB:1RPY"
FT   HELIX           469..486
FT                   /evidence="ECO:0007829|PDB:1RPY"
SQ   SEQUENCE   621 AA;  66708 MW;  4E019DF3A73D5B4F CRC64;
     MNGATPGSAA APAPVPDWRQ FCELHAQVAA VDFAHKFCRF LRDNPTYDTP DAGTSFSRHF
     AANFLAVFSE EVRRVLGTAA DTMEPEPAVT SVTSALKTAT YGHSRSSEDV SAHVATKARV
     RKGFSLRNMS LCVVDGVRDL WHRRASPEPE GGATPKTTEP VSEPRDKWTR RLRLARTLAA
     KVELVDIQRE GALRFMVADD AASGPGGTAQ WQKCRLLLRR AVAGERFRLE FFVPPKASRP
     KVSIPLSAII EVRTTMPLEM PEKDNTFVLK VENGAEYILE TIDSLQKHSW VADIQGCVDP
     GDSEEDTGLS CARGGCLASR VTSCSCELLT EADMPRPPET MTAVGAVVTA PHGRARDTVG
     ESLAHVPLET FLQTLESSGG VSESNNTGDE GAELDPDAEA ELELSDYPWF HGTLSRVKAA
     QLVLAGGPRS HGLFVIRQSE TRPGECVLTF NFQGKAKHLR LSLNGHGQCH VQHLWFQSVF
     DMLRHFHTHP IPLESGGSAD ITLRSYVRAQ GPPPDPGPAP NTAAPVPACW TEPAGQHYFS
     SLATATCPPT SPSNGAGASS SSGSSSSATS VPPRPAEGPL SARSRSNSTE HLLEAASGAT
     EEPADATLGR ARAVENQYSF Y
//
